Octavia M. Peck Palmer, PhD Appointed as new Board Member of Project Santa Fe Foundation
Project Santa Fe Foundation (PSFF), the not-for-profit accelerating the Clinical Lab 2.0 movement (CL2.0) and defining the future valuation of the clinical laboratory, proudly announces the unanimous election of Octavia M. Peck Palmer, PhD, as its newest board member. “I am happy to join the Project Santa Fe Foundation Board. I look forward to learning and contributing to the establishment of standards to effectively utilize laboratory medicine data for the enhancement of patient and population health.”
Octavia M. Peck Palmer is academically unique as she conducts translational research, teaches, mentors, and directs clinical laboratories within the University of Pittsburgh Medical Center (UPMC) organization. She is a board-certified clinical chemist and Associate Professor in the Department of Pathology at the University of Pittsburgh School of Medicine, with secondary faculty appointments within the Critical Care Medicine and Clinical and Translational Science departments. She is also the Division Director of Clinical Chemistry and directs CAP-accredited clinical laboratories that perform patient testing and provide both consultative and patient test result interpretation for healthcare providers within the healthcare organization. On July 1, 2023, Octavia was appointed the inaugural Vice Chair of Health Equity, Diversity, & Inclusion for the Department of Pathology.
Dr. Palmer is the Immediate Past President of the Association for Diagnostics & Laboratory (ADLM) Medicine, formerly AACC. In her academic and clinical roles, she teaches and mentors, conducts externally funded translational science research focused on infectious disease/sepsis, and laboratory diagnostics and quality, and Laboratory Medicine’s role in identifying and eliminating health disparities, and provides technical expertise and clinical consultation to the healthcare system to ensure accurate and timely patient test results and regulatory compliance.
“We couldn’t be more thrilled to welcome Dr. Palmer to the Clinical Lab 2.0 movement. Together, we look forward to collaborating on advancing the role of clinical laboratories in creating sustainable healthcare, enhancing population health, and promoting value-based care,” remarks Khosrow Shotorbani. President, and CEO Project Santa Fe Foundation. Dr. Jim Crawford, Chair of the Board of Directors adds, “The Project Santa Fe Foundation is thrilled to have Dr. Peck Palmer joining the board. She is a highly-recognized leader in the industry, and brings extraordinary expertise to the Clinical Lab 2.0 movement. This includes her leadership in the realm of health equity and access to health care, an area where clinical laboratories can play a critical role.”
About Project Santa Fe Foundation & Clinical Lab 2.0
Project Santa Fe Foundation LLC (PSFF), 501c3, is a coalition of laboratory leaders, coming together to create a disruptive value paradigm and explore alternative business models that expand the role of diagnostic services in the future healthcare ecosystem. PSFF leverages laboratory medicine and pathology domain knowledge to establish the thought leadership, standards and evidence for Clinical Lab 2.0. Through the facilitation of diverse partner collaborations, PSFF aims to guide policies, transfer the knowledge and accelerate the Clinical Lab 2.0 movement across the industry. www.cl2lab.org